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Abstract 
Long-term storage of whole blood can affect the integrity of DNA if it is not done under 
optimal conditions. The aim of this study was to determine whether long-term storage (2 
- 19 years) of whole blood samples at -30°C had a negative effect on the quality or quantity 
of genomic DNA that could be recovered at extraction. Genomic DNA was isolated from 
2758 whole blood samples collected in 4 ml EDTA vacutainers from 1997 to 2012. DNA 
was extracted using the Qiagen® FlexiGene® DNA kit. The average storage duration at -
30°C was 12 years. The quality and quantity of the isolated DNA were assessed using 
spectrophotometry (NanoDrop™), a fluorometric assay for double-stranded DNA 
(Qubit™) and agarose gel electrophoresis. The mean DNA yield per sample was found to 
be 114 µg from whole blood volumes which ranged from 0.5 ml to 4 ml. The mean 
A260/280 ratio and median A260/280 ratios were both 1.8. No correlation was found 
between the duration of storage and the total yield or the quality of DNA extracted. These 
data suggest that high quality DNA can be extracted from whole blood samples that are 
stored at -30°C for up to 19 years.   
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Introduction 
DNA can be isolated from almost all body tissues including bodily fluids 1. Due to its relative 
ease of acquisition, whole blood provides one of the most common sources of high quantity 
and quality DNA for molecular applications, including clinical and epidemiological studies 2.  
Large genetic epidemiological studies can involve the collection of tens of thousands of 
valuable whole blood samples that can be, or have been, stored for many years. The blood 
volume available for DNA extractions is an obvious indicator of DNA yield 3. However, long-
term storage conditions of whole blood can affect the integrity of DNA 4. Blood samples stored 
at 4°C for a short period of time will still yield DNA of acceptable quality provided the correct 
blood collection tubes were used 1,5. However the desired temperature for whole blood samples 
for DNA isolation is at -80°C for long-term storage 4. Whole blood samples can also be frozen 
at -20°C for long-term storage 4,6,7, however, other studies have found lower DNA yields 
following this approach 1,7. A study by Di Pietro et al (2011) found that whole blood samples 
stored for long periods at -20°C yielded high quality DNA for genotyping studies, although the 
sample size was small (n=82) 8. 
The current study sought to determine whether the duration of the long-term storage of whole 
blood samples, using a large sample size (n=2758), stored at a stable -30°C, has a negative 
effect on the quality and quantity of the genomic DNA extracted. 
 
Materials and Methods  
Samples 
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Samples analysed were sourced from the Johannesburg Cancer Case Control Study (JCS) at 
the National Cancer Registry (NCR) of South Africa. The JCS is a large, recently (2016) ended 
case-control study established in 1995 9. In brief, the JCS recruited newly diagnosed cancer 
patients of black African ancestry. These patients were interviewed by trained research nurses 
and their blood was collected with informed consent for future research as approved by the 
Research Ethics Committee at the University of the Witwatersrand and described by Urban et 
al. 9. Blood samples were drawn from the patients in 4 ml EDTA vacutainers and were stored 
in -30°C freezers until further use. More than 20000 whole blood samples (representing various 
cancer types) have been collected since March 1995 for the JCS, of which a subset of 2758 
blood samples were used for this study. DNA extractions were performed on request for 
specific studies in collaboration with the JCS. At the time of the study being reported here, 
DNA had been extracted from 2758 blood samples for four different studies. Ethical approval 
was obtained from the University of the Witwatersrand Human Research Ethics Committee 
(Medical), clearance numbers: M140271 and M120117. 
Sample Storage 
All blood samples collected under the JCS were kept at room temperature until collected for 
transport. The blood samples were then transported in a cooler box with an ice block from the 
three separate study sites to a centralized storage facility. On the rare occasion that there was 
an issue with the transportation, samples were frozen at the collection site and collected at the 
next available time. Average transit time was ≤ 30 minutes. All samples were frozen in their 
collection tubes in an upright position at -30°C within a maximum of 24 hours of collection. 
Miele™ -30°C general freezers were used for sample storage. The freezers’ temperatures were 
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monitored with an alarm-based system and back-up freezers were available. As part of our risk 
management strategy, when a freezer failed, the samples were transferred to another freezer 
prior to thawing. All the blood samples were frozen in an upright position and thereafter stored 
on their sides. Although the blood was collected in a 4 ml EDTA tube, not all were filled to 
capacity; therefore, the volume of the blood sample available for extraction was noted prior to 
DNA extraction. Sample information was managed using Microsoft Excel and then 
incorporated into a STATA database. 
DNA Isolation 
Whole blood samples collected between 1997 and 2012 (n=2758) were extracted. DNA 
extraction procedures occurred in batches between May 2013 and June 2016. Six different 
technicians were involved over the four-year period. The technicians were trained on the 
extraction protocol, blinded to the storage duration of the blood samples and each technician 
extracted samples collected over the whole-time period. Total genomic DNA was isolated 
using the FlexiGene® DNA Kit (Qiagen®). This kit was chosen initially for its ability to handle 
a diverse range of input blood volume and then used subsequently for consistency. Extractions 
were undertaken following the manufacturer’s protocol, with the following minor 
modifications: the use of a dry heat incubator instead of a hot water bath, and resuspension of 
the DNA pellet in 1x TE buffer (Invitrogen™) instead of the supplied FG3 buffer. To ensure 
no wastage and optimum yield, the entire blood volume in a tube was used for DNA extraction. 
Two fixed protocols, one for samples with <2 ml of blood and the other for >2 ml, were 
optimized and used per the manufacturer’s procedures. The most noticeable difference between 
protocols was the use of 50 ml Nunc tubes for samples with blood volumes of >2 ml, rather 
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than the 15 ml Nunc tubes used for samples with blood volumes of <2 ml. Reagent volumes 
were adjusted per the sample volume (per manufacturer’s protocol). The centrifugation 
conditions were unchanged. No RNAse digestion was incorporated into the DNA isolation 
protocol. 
DNA Quantity and Quality 
DNA quantity and purity were assessed spectrophotometrically using the NanoDrop™ 1000 
(Thermo Scientific™) directly after extraction and prior to storage at -30°C. DNA 
concentration was measured and DNA purity was calculated through the standard A260/280 
and A260/230 ratios. This is a fast and accurate technique for determining DNA concentration 
of pure samples 10. DNA/RNA and proteins have their maximum absorbance at 260 and 280 
nm, respectively. An A260/280 ratio of ~1.8 is generally accepted as a reflection of a pure 
DNA sample and a ratio of ~2.0 is generally accepted as pure for RNA. A secondary 
measurement of the A260/230 ratio is used to determine the purity of DNA against other 
contaminants. A higher A260/230 is expected for pure DNA (~2.0-2.2). Low A260/230 ratios 
indicate the presence of contamination or proteins that absorb light at the 230 nm wavelength 
11.  
Genomic DNA integrity assessment was done, at a later stage, using gel electrophoresis for 
218 samples selected at random (4 – 19 years storage, mean = 12 years) (Figure 1). Genomic 
DNA was resolved on 0.8% agarose gel, stained with GelRed™, at 8 V/cm for 45 minutes 
against the GeneRuler 1kb Plus DNA Ladder (Thermo Scientific™).   
DNA quantitation was additionally assessed using a second methodology. Qubit fluorometry 
was performed using the Qubit™ 3.0 Fluorometer (Thermo Scientific™). This method uses 
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the double stranded DNA (dsDNA) BR (Broad Range) assay to quantify dsDNA, as opposed 
to single stranded DNA (ssDNA), present in a sample. Only a subset of samples (n=200) were 
quantified using this chemistry owing to cost restraints. The 200 samples were randomly 
selected for year of collection (2 - 19 years of storage), with concentrations representative of 
the overall DNA concentration range.  This measures dsDNA concentration only, which 
provides a more useful reading as contaminants, including degraded DNA and RNA, are not 
measured. The %dsDNA was calculated by dividing the Qubit™ concentration by the 
Nanodrop™ concentration and multiplying by 100. 
Analysis 
Descriptive statistics were compiled by years of storage. Means and medians were calculated 
for DNA yields, DNA concentrations, blood volume available per sample, DNA yield per ml 
of blood, A260/280 and A260/230. Both means and medians were compiled given the non-
normally distributed nature of the data which may limit the mean accuracy. 
Spearman’s ranked correlations were performed to determine whether duration of storage 
(years) of the samples, blood volume available for extraction, and the age of participants 
correlated with the total DNA yields. Samples (n=564) without blood volume data were 
excluded. 
Kruskal-Wallis H tests, with multiple group comparisons, were performed to determine 
whether DNA yields, A260/280 and A260/230 ratios, differed between the different years of 
storage duration. Kruskal-Wallis H tests was also used to determine differences in mean DNA 
yield per ml of blood across different storage durations as well as to determine differences in 
mean total DNA yields measured by Qubit™ and differences in mean percentage of dsDNA 
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(%dsDNA) across different storage durations. Nonparametric test for trend was performed to 
evaluate the relationship between %dsDNA across the storage duration of the blood samples. 
Quantile regression estimating the conditional median was performed to model the effect of 
storage duration of the blood samples, blood volume available for DNA extraction, age and 
gender of the participants had on the %dsDNA.  
A Two-sample t test with equal variances were performed to assess the difference in mean 
DNA yield per 1 ml of blood between the two different DNA extraction protocols as well as 
mean DNA yield per 1 ml of blood between cancer samples and non-cancer samples and 
between HIV positive and HIV negative samples.  
 
Results 
Total genomic DNA was isolated from a total of 2758 samples collected between 1997 and 
2012 for the JCS (Table 1). NanoDrop™ data were used to calculate DNA yield, DNA 
concentration, and to determine A260/280 and A260/230 ratios. Blood samples were stored on 
average for 11.9 years. The longest storage period of samples before DNA extraction was 19 
years (n=125) and the shortest was 2 years (n=31) (Table 1). Information on the volume of 
blood collected was available for 80% (n=2206) of all samples (Table 1). Freezers were 
monitored closely so that no thawing of samples (resulting from freezer failures) happened 
during this study.  
(Insert Table 1) 
The quality (A260/280 and A260/230 ratios), concentration (ng/µl) and the quantity of isolated 
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DNA (µg), and the mean and median concentration per year of storage for the samples are 
shown in Table 1. The mean A260/280 ratio across all samples was 1.79 and median A260/280 
ratio was 1.8, suggesting good quality DNA was isolated. The mean A260/230 ratio across all 
samples was 1.71 and the median A260/230 ratio was 1.78, less than 2.0, suggesting the 
presence of protein, contaminants or RNA residues which absorb at 230 nm or less.  
Genomic DNA from 218 samples was subjected to agarose gel electrophoresis to assess 
possible degradation. High molecular weight staining was observed for all 218 samples. Figure 
1 shows a representation of the gel electrophoresis result for a representative subset of samples 
which had been stored for different periods of time. A consistent low level of partial 
degradation (low intensity of smearing from the genomic band down to 3 kb) was noted across 
most samples analysed on gel electrophoresis. The consistency of this smearing pattern 
suggests that this is likely an artefact from the DNA isolation protocol that caused DNA 
smearing rather than storage related DNA degradation.    
(Insert Figure 1) 
The DNA yields of samples per year of storage clustered tightly together, except for a few 
outlier samples with very high DNA yields or extremely low DNA yield (Figure 3). The 
presence of the outliers illustrates the value of the median as a more informative reporting tool 
than the mean. 
The average yield for all samples was 108.95 µg as measured by NanoDrop™, whereas the 
average yield for the 200 samples measured by Qubit™ was 86.19 µg per sample. This 
indicates that approximately 79% of total DNA measured by spectrophotometry was dsDNA, 
with the remaining proportion presumed to be ssDNA and/or denatured or degraded DNA. A 
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plot of dsDNA percentage against the storage duration is shown in Figure 2. 
(Insert Figure 2) 
 A Kruskal-Wallis H test showed no statistically significant differences exist between the mean 
total DNA yield by Qubit™ measurements and the number of years of storage (p = 0.46) and 
no statistically significant differences exist between the mean percentage of dsDNA and the 
number of years of storage (p = 0.10). Nonparametric trend analysis for %dsDNA, quantified 
by Qubit™ across the storage durations indicated a positive trend (z = 6.24, p < 0.001), with 
the %dsDNA increasing with increased storage duration of the blood samples. However, 
storage duration of the blood samples had a negligible effect on %dsDNA after adjusting for 
blood volume used for extraction, age and gender (beta = 0.01, p = 0.045).    
Spearman’s ranked correlation was performed to assess the relationship between total DNA 
yields, storage duration of blood samples, blood volumes available for extractions, and age of 
participants at recruitment using 2194 samples. After Bonferroni correction, there was a strong 
positive correlation observed between the total blood volumes available for extractions and the 
total DNA yield, which was statistically significant, rs = 0.2258, p < 0.0001. So, the more total 
volume of blood available the more total DNA yield there was. There was no evidence of 
correlation between storage duration of blood samples or age of participants at recruitment with 
total DNA yields. There was no evidence of correlation between total blood volume with 
A260/280 or A260/230 ratios.  
A Kruskal-Wallis H test, after Bonferroni correction and correcting for technician variability, 
showed no statistically significant differences exist between the DNA yields, A260/280 or, 
A260/230 ratios and the number of years of storage. As expected, total blood volume is a direct 
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indicator of amount of total DNA available (rs = 0.2258, p < 0.0001). Similarly, no statistically 
significant differences were observed between the mean DNA yield per ml of blood and the 
storage duration of the blood sample (p = 0.25). 
The FlexiGene® DNA Kit (Qiagen®) gave an expected DNA yield of 37.5 µg per 1 ml of blood 
assuming a normal white cell count of 7 x 106 cells/ml blood 12. JCS sample yield was between 
25.83 µg and 46.54 µg (mean = 37.77 µg) of DNA per 1 ml of blood. 
The effect of the optimized protocols for different sample blood volumes were assessed using 
a two-sample t test with equal variances. Samples with blood volumes of <2 ml or less (n=403) 
yielded more DNA per 1 ml of blood (44.12 µg, 95% CI: 39.73 - 48.51 µg) when compared to 
DNA yielded per 1 ml of blood for samples with blood volumes of more than 2 ml (n=1792) 
(36.79 µg, 95% CI: 35.42 - 38.16 µg) (p = 0.0001). The typical DNA yields of the FlexiGene® 
kit for a 2 ml volume would be 33-45 ug/ml. No difference in mean DNA yield per 1 ml of 
blood was observed between cancer samples (n=1482) and non-cancer samples (n=707) (p = 
0.50). A difference in mean DNA yield per 1 ml of blood was observed between HIV positive 
(n=1851) and HIV negative samples (n=313), with HIV negative samples (38.70 µg, 95% CI: 
37.23 - 40.17 µg) yielding ~5 µg DNA more per ml than HIV positive samples (33.36 µg, 95% 
CI: 29.39 - 37.32 µg) (p = 0.0076). 
(Insert Figure 3) 
(Insert Figure 4A) 
(Insert Figure 4B) 
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Discussion  
This study was undertaken to answer questions about the expected quality and quantity of DNA 
isolated from whole blood samples that have been stored at -30°C for between 2 and 19 years. 
The concern was that long-term storage of whole blood at -30°C may have a negative effect on 
quality and/or quantity of the DNA 7. Genomic DNA was isolated from 2758 blood samples 
collected between 1997 and 2012 using the Qiagen FlexiGene® DNA kit.  To our knowledge 
this is the largest study of its kind assessing the quality and quantity of DNA isolated from 
frozen blood samples stored for long periods.  
The results from our study are unique from previous findings 1,7 as we used a different DNA 
extraction method (kit versus salting out or phenol/chloroform), stored samples at -30°C 
temperature (compared to room temperature and 4°C) and used a much larger sample size. The 
large sample size of our study affords greater statistical power to evaluate the relationship 
between DNA yields and storage duration of the blood samples. A recent publication looking 
at various storage conditions on forensic examinations of blood samples and blood stains (n=6) 
concluded that to prevent DNA degradation during long term (20 year) storage, they be stored 
at below -20°C 16, such as our samples have been. We have a much larger sample size with 
varying lengths of storage to assess and have found that the quantity of DNA is not affected, 
and are fairly confident that the same can be said about the quality.  
This study found that long-term storage of whole blood samples at -30°C does not have a 
negative effect on the quality and quantity of the DNA extracted. The average duration of 
storage was approximately 12 years. The mean A260/280 ratios were found to be 
approximately 1.8 across all the years of collection, suggesting high purity of the DNA 
13 
 
regardless of the duration of blood storage (Figure 4A). The lower than expected A260/230 
ratios indicate the presence of other organic residues (Figure 4B). The source of the organic 
residues is likely artefacts resulting from the inadequate removal of organic chemicals used in 
the extraction chemistry.  
The DNA yield was expected to decrease for samples stored for longer periods. Alrokayan 
reported a 30 to 40% decrease in total DNA yield for whole blood samples frozen at -20°C 7. 
A decrease in DNA yield was not observed in the JCS samples extracted, as no correlation 
between storage duration and total DNA yields was observed. Assuming the blood samples are 
stored within the desired temperature range at stable conditions, DNA can be extracted from 
these samples after prolonged storage. DNA yields of samples per year of collection clustered 
tightly together for the 2 to 19 years, except for a few outliers (Figure 3).  
High quality dsDNA is preferred for downstream applications such as PCR, microarray 
analysis or next generation sequencing analysis. Qubit™ is well known to be a more sensitive 
method to quantify DNA, as compared to the NanoDrop™ 13,14. Qubit™ readings are lower 
than NanoDrop™ readings as they do not measure single stranded, degraded DNA 13,14. Our 
results showed that, on average, 79% of total DNA measured by NanoDrop™ was dsDNA. 
From the subset of samples that was analysed on Qubit™, the %dsDNA did not decrease with 
increased years of storage (p = 0.10); instead a positive trend was seen with increasing storage 
duration but the effect size was minimal (beta = 0.01, p = 0.045). This supports our hypothesis 
that storage duration of the blood samples does not influence DNA quality. It is worth noting 
that although DNA was extracted from these archived blood samples, no assessments were 
done for RNA, micro RNA, cell-free circulating DNA or proteins. 
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The DNA yields are in line with expected yields cited by the manufacturers. With every 
additional 1 ml of blood volume available for extraction, the DNA yield would be expected to 
increase by 20.94 µg (p<0.01). The DNA yield per ml of blood does not increase when more 
blood was processed. Rather optimization of the DNA extraction protocol used for different 
volumes of blood affects the DNA yield per ml of blood. Two fixed protocols were used in this 
study, the protocol for sample volumes of <2 ml of blood yielded ~7 µg (P = 0.0001) more 
DNA per ml of blood than the protocol used for samples of >2 ml of blood. This is possibly 
due to the extra time and care given per extraction for the small volumes of these samples 
because of the limited volume. It is possible that the potential yield could be improved by 
optimising the extraction protocol to the exact blood volume available. This would however 
require extra laboratory time and staff.  
The patients’ age may also influence the number of white cells available 5,15. In older patients 
there is often a decline in the quantity of DNA due to a reduction in the number of leukocytes 
and lymphocytes with age progression 17. However, this correlation was not observed in this 
study. As anticipated, samples from individuals that were HIV positive at the time of sampling 
had a lower DNA yield as a likely consequence of fewer peripheral blood mononuclear cells 
due to the infection. However, no difference in mean yield was observed between cancer 
samples and non-cancer samples. 
One limitation of this study was that gel electrophoresis and fluorometry was not done for all 
2758 samples to assess the integrity of the extracted DNA at the beginning of DNA storage. 
Hence the data lack robustness to definitively conclude that long-term storage of blood samples 
does not negatively affect DNA integrity. However, from the representative subset of samples 
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(n=200) that were assessed by gel electrophoresis, the authors are confident that the DNA 
integrity of DNA extracted from long-term stored blood samples are sound. A comprehensive 
analysis would include doing a quantitative PCR or a long-range PCR and we have applied for 
funding to do this. We have used these samples in other genotyping studies and they have 
produced adequate genotyping call rates (unpublished).   
From the results of this large study, the authors are confident that long term storage (average 
11.9 years) of whole blood samples stored in 4 ml EDTA vacutainers at a stable -30°C does not 
have a negative effect on the quality and quantity of the DNA. The authors are also confident 
that the DNA integrity assessment done on a representative sample is sufficient to represent 
the larger cohort. Despite the limitations of this study, we found no evidence that DNA integrity 
worsened over prolonged period of blood sample storage. Archived whole blood samples can 
still be utilised in genetic epidemiology studies provided the blood samples are stored correctly 
with constant temperature monitoring to prevent freeze-thaw episodes.   
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